Search results
Results from the WOW.Com Content Network
eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 17.033), also published by The Lancet. [1]
Cancer is a biweekly peer-reviewed scientific journal covering oncology. The journal was established in 1948. It is an official journal of the American Cancer Society and is published by Wiley-Blackwell on behalf of the society. The first editor-in-chief was Fred W. Stewart, who held that position until 1961.
It is affiliated with the African Organization for Research and Training in Cancer. The editors-in-chief are Franco M. Buonaguro (Istituto Nazionale Tumori), Sam M. Mbulaiteye (National Cancer Institute) and Maria Lina Tornesello (Istituto Nazionale Tumori). According to the Journal Citation Reports, the journal has a 2021 impact factor of 3. ...
Cancers is a peer-reviewed, open access, medical journal published by MDPI covering all fields of oncology. [1] The editor-in-chief is Samuel C. Mok (The University of Texas MD Anderson Cancer Center). The Irish Association for Cancer Research (IACR) and the Signal Transduction Society (STS) are affiliated societies.
Cancer Informatics; Computational and Structural Biotechnology Journal; Computational Biology and Chemistry; Computers in Biology and Medicine; Current Bioinformatics;
Cancer Medicine is a monthly peer-reviewed open-access medical journal covering oncology. It was established in 2012 and is published by John Wiley & Sons. The editor-in-chief is Stephen Tait (Institute of Cancer Sciences, University of Glasgow). According to the Journal Citation Reports, the journal has a 2020 impact factor of 4.452. [1]
The editors-in-chief are Vincent T. DeVita (Yale Cancer Center), Theodore S. Lawrence (University of Michigan), and Steven Rosenberg (National Cancer Institute). According to the Journal Citation Reports, the journal has a 2022 impact factor of 2.2, ranking it 199th out of 241 journals in the category "Oncology". [1]
The journal is abstracted and indexed in Medline, BIOSIS Previews, [11] Chemical Abstracts Service, [12] Science Citation Index Expanded, [11] and Scopus. [13] According to the Journal Citation Reports, the journal has a 2023 impact factor of 6.4. [14] The journal opposes the over-reliance on the impact factor by the scientific community. [15]